Partner With Us NRI

Advanced Enzyme Technologies Ltd share Price

Company details

6M Return 37.80%
1Y Return 11.30%
Mkt Cap.(Cr) 3,536.43
Volume 50,468
Div Yield 0.32%
OI Chg %
Volume 50,468

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
About The Stock

    Advanced Enzyme Technologies (AET) is a focused, research driven Indian enzymes company with a product basket of 400+ proprietary products developed from 68 indigenous enzymes and probiotics.

    • The business is divided into three segments - 1) human healthcare, 2) animal healthcare and 3) industrial processing business
    • It has seven manufacturing and six R&D facilities, which consist of three integrated fermentations, recovery & formulation facilities, one extraction and recovery facility and one satellite blending, mixing & formulation facility

    Margin pressure and poor demand offtake continues to weigh.

    • Revenues were down 1% YoY to ₹ 132 crore
    • EBITDA was at ₹ 40.3 crore, down 26.6% YoY with margins at 30.6%
    • Adjusted PAT was at ₹ 24.4 crore (down 22.9% YoY)

Click here for full recommendation

Research view on more stocks

Biotechnology company Advanced Enzyme Technologies announced Q1FY24 results:

  • Revenue from operations on a consolidated basis increased to Rs 1,473 million in Q1FY24 from Rs 1,211 million in Q1FY23, a growth of 22%.
  • Consolidated EBITDA during Q1FY24 stands at Rs 440 million as compared to Rs 309 million during Q1FY23, an increase of 42%.
  • Profit before tax stands at Rs 414 million during Q1FY24 as against Rs 237 million in Q1FY23, an increase of 75%.
  • Profit after tax grew by 67% and stands at Rs 294 million during Q1FY24 as compared to Rs 176 million during Q1FY23.
  • EBITDA margin stands at 30%, PBT margin stands at 28% and PAT margin stands at 20% during Q1FY24.
  • Financial costs stood at Rs 7 million during Q1FY24 as against Rs 6 million in Q1FY23.
  • Depreciation and Amortization charges for Q1FY24 remain unchanged at Rs 86 million as compared to Q1FY23.
  • Earnings Per Share during Q1FY24 stands at Rs 2.58 as compared to Rs 1.60 in Q1FY23.



Result PDF

View Other Company Results


Investment recommendation
Call Date
06 Aug 2022
Entry Price 293.00
Target Price 265.00
12-18 Month


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Advanced Enzyme Technologies Ltd Stocks COMPARISION


Equity Capital: 1,235.07 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 18,014.89 -11,775.55
LAST 3M 48,885.55 -315.90
LAST 6M 51,016.24 146,552.89
LAST 12M 134,434.58 164,088.22

Advanced Enzyme Technologies Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Advanced Enzyme Technologies Limited is a manufacturing enzymes sector company having a market capitalization of is 5,100.96 Crores as of 15-May-2021. The company was incorporated in 1945. The company has reported its consolidated quarterly revenue of Rs. 139.09 Cr. at the end of December 2020. The company is found listed on the Bombay Stock Exchange (BSE) with the code 540025 and also listed on National Stock Exchange (NSE) with the symbol ADVENZYMES. Advanced Enzymes is the largest Indian enzyme company engaged in the research and development dedicated to marketing eco-safe solutions to a wide variety of industries like Pharmaceuticals, Baking, Agriculture, Waste Management, Textile, Leather, Distilling, Grain Processing, Juice Processing, etc, developed from over 65 indigenous enzymes & probiotics. As of March 31, 2020, the Company has 6 (six) direct subsidiaries and 5 (five) step-down subsidiaries. Out of which 3 (three) are Indian subsidiaries and 8 (eight) are foreign subsidiaries make a strong presence across 45 countries worldwide. With exports across 6 continents, they provide customized and effective enzyme solutions coupled with the best in technical advice and superior service. 20 patents. The company has granted more than 20 patents, currently having more than 550 employees, more than 25 years of fragmentation experience. The current fragmentation capacity of AETL is 470 m³. To strength, its product, Company spending on R & D as a percentage of turnover is increasing from past 4 years( As per March 2020, R & D cost to total turnover is 4.95%) Advanced Enzyme Technologies Limited (AETL) is having is earning 43% revenue from India and 57% revenue internationally. ATL is having high TTM EPS growth with Low debt. For F.Y 19-20. Annual net profits and Book value per share also increasing for the past 2 years. ATL is a company having zero promoter pledges and Strong cash-generating ability from its core business. As on 31-March 20, AETL is a company having zero promoter pledge and Strong cash-generating ability from core business.

Registered Address

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Tel : 91-22-41703200
Email : info:advancedenzymes.com
Website : http://www.advancedenzymes.com

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
Book Closure Date (Month) :
BSE Group : B
ISIN : INE837H01020

FAQ’s on Advanced Enzyme Technologies Ltd Shares

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 28, 2023 12:49 PM the closing price of Advanced Enzyme Technologies Ltd was ₹ 316.25.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Sep 28, 2023 12:49 PM, the market cap of Advanced Enzyme Technologies Ltd stood at ₹ 3,536.43.

The latest PE ratio of Advanced Enzyme Technologies Ltd as of Sep 28, 2023 12:49 PM is 29.72

The latest PB ratio of Advanced Enzyme Technologies Ltd as of Sep 28, 2023 12:49 PM is 0.35

The 52-week high of Advanced Enzyme Technologies Ltd is ₹ 346.55 while the 52-week low is ₹ 225.00

According to analyst recommendations, Advanced Enzyme Technologies Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app